Influx Healthtech Quarterly Results for Trading Insights
INFLUX • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹13 Cr
QMarch 2025
Influx Healthtech Quarterly Results Key Highlights
- Revenue of ₹105 Cr in March 2025 (+0.0% vs March 2025, +5.0% vs March 2024)
- Net Profit of ₹13 Cr in March 2025 (+0.0% vs March 2025, +18.2% vs March 2024)
- EBITDA of ₹21 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 20.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹7.36 in March 2025 (+0.0% vs March 2025)
Influx Healthtech Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 105 | 100 | 76 | 59 | - | - |
| Net Profit (₹ Cr) | 0 | 13 | 11 | 7 | 5 | - | - |
| EBITDA (₹ Cr) | 0 | 21 | 17 | 11 | 6 | - | - |
| EPS (₹) | 0.00 | 7.36 | 6.13 | 3.96 | 1801.90 | - | - |
| Operating Margin (%) | 0.0% | 20.0% | 17.0% | 14.0% | 11.0% | - | - |
Influx Healthtech Share Price Trend Around Quarterly Results
Visualize Influx Healthtech's 1-year price movement across quarterly results — ideal for logging trades in Influx Healthtech share price
chart using Tickjournal. All values in ₹.
Related Pages for Influx Healthtech
Additional stock information and data for INFLUX
Revenue Trend (₹ Cr)
March 2023
76
March 2024
100
March 2025
105
2026
0
Net Profit Trend (₹ Cr)
March 2023
7
March 2024
11
March 2025
13
2026
0
Operating Margin Trend (%)
March 2023
14.0%
March 2024
17.0%
March 2025
20.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Influx Healthtech quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.7 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6600.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4026.4 | 3,219 | 591 | +11.3% | - | 18.4% | 229.6 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1460.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1206.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores